Search Results 2501-2510 of 17053 for pharmacogenetics
ROCHESTER, Minn. — Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis patients at higher risk of dying from ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns ...
A clinician-researcher whose interest in collagen biology and improving the lives of patients drove his passion for discovering the first federally-approved ...
TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...
Mayo Clinic Minute: How personalized vaccines target cancer tumors featured image · Mayo Clinic contributes to national Alzheimer's disease research priorities ...
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could ...
Panobinostat and everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
This episode of "Tomorrow's Cure" explores the dramatic changes happening in pediatric care thanks to whole genome sequencing. Hear from Whitney Thompson, M.D., ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed and tested a new 3D surface scanning approach that gives neurosurgeons even greater precision when ...
Mayo Clinic researchers are using technology to produce tissue models of different body parts to study damaged or diseased tissues and organs. They envision a[.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.